TY  - CONF
AU  - Bouchet, Samuel
AU  - Linot, Camille
AU  - Ružić, Dušan
AU  - Agbaba, Danica
AU  - Fouchaq, Benoit
AU  - Roche, Joëlle
AU  - Nikolić, Katarina
AU  - bl, Christophe
AU  - Zwick, Vincent
AU  - Nurisso, Alessandra
AU  - Simoes-Pires, Claudia
AU  - Lehotzky, Attila
AU  - Ovadi, Judit
AU  - Cuendet, Muriel
AU  - Bertrand, Philippe
PY  - 2018
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4927
C3  - 4th International Epigenetic congress EpiNanties 2018, 16-17. October 2018, Nanties, France.
T1  - Development of cross metathesis  for the design of HDAC inhibitors
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4927
ER  - 

@conference{
author = "Bouchet, Samuel and Linot, Camille and Ružić, Dušan and Agbaba, Danica and Fouchaq, Benoit and Roche, Joëlle and Nikolić, Katarina and bl, Christophe and Zwick, Vincent and Nurisso, Alessandra and Simoes-Pires, Claudia and Lehotzky, Attila and Ovadi, Judit and Cuendet, Muriel and Bertrand, Philippe",
year = "2018",
journal = "4th International Epigenetic congress EpiNanties 2018, 16-17. October 2018, Nanties, France.",
title = "Development of cross metathesis  for the design of HDAC inhibitors",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4927"
}

Bouchet, S., Linot, C., Ružić, D., Agbaba, D., Fouchaq, B., Roche, J., Nikolić, K., bl, C., Zwick, V., Nurisso, A., Simoes-Pires, C., Lehotzky, A., Ovadi, J., Cuendet, M.,& Bertrand, P.. (2018). Development of cross metathesis  for the design of HDAC inhibitors. in 4th International Epigenetic congress EpiNanties 2018, 16-17. October 2018, Nanties, France..
https://hdl.handle.net/21.15107/rcub_farfar_4927

Bouchet S, Linot C, Ružić D, Agbaba D, Fouchaq B, Roche J, Nikolić K, bl C, Zwick V, Nurisso A, Simoes-Pires C, Lehotzky A, Ovadi J, Cuendet M, Bertrand P. Development of cross metathesis  for the design of HDAC inhibitors. in 4th International Epigenetic congress EpiNanties 2018, 16-17. October 2018, Nanties, France.. 2018;.
https://hdl.handle.net/21.15107/rcub_farfar_4927 .

Bouchet, Samuel, Linot, Camille, Ružić, Dušan, Agbaba, Danica, Fouchaq, Benoit, Roche, Joëlle, Nikolić, Katarina, bl, Christophe, Zwick, Vincent, Nurisso, Alessandra, Simoes-Pires, Claudia, Lehotzky, Attila, Ovadi, Judit, Cuendet, Muriel, Bertrand, Philippe, "Development of cross metathesis  for the design of HDAC inhibitors" in 4th International Epigenetic congress EpiNanties 2018, 16-17. October 2018, Nanties, France. (2018),
https://hdl.handle.net/21.15107/rcub_farfar_4927 .

TY  - CONF
AU  - Bouchet, Samuel
AU  - Linot, Camille
AU  - Ružić, Dušan
AU  - Agbaba, Danica
AU  - Fouchaq, Benoit
AU  - Roche, Joëlle
AU  - Nikolić, Katarina
AU  - Cuendet, Muriel
AU  - Ovádi, Judit
AU  - Blanquart, Christophe
AU  - Bertrand, Philippe
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/4926
PB  - European Cooperation in Science and Technology (COST)
C3  - EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017
T1  - Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design
SP  - 19
EP  - 19
UR  - https://hdl.handle.net/21.15107/rcub_farfar_4926
ER  - 

@conference{
author = "Bouchet, Samuel and Linot, Camille and Ružić, Dušan and Agbaba, Danica and Fouchaq, Benoit and Roche, Joëlle and Nikolić, Katarina and Cuendet, Muriel and Ovádi, Judit and Blanquart, Christophe and Bertrand, Philippe",
year = "2017",
publisher = "European Cooperation in Science and Technology (COST)",
journal = "EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017",
title = "Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design",
pages = "19-19",
url = "https://hdl.handle.net/21.15107/rcub_farfar_4926"
}

Bouchet, S., Linot, C., Ružić, D., Agbaba, D., Fouchaq, B., Roche, J., Nikolić, K., Cuendet, M., Ovádi, J., Blanquart, C.,& Bertrand, P.. (2017). Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design. in EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017
European Cooperation in Science and Technology (COST)., 19-19.
https://hdl.handle.net/21.15107/rcub_farfar_4926

Bouchet S, Linot C, Ružić D, Agbaba D, Fouchaq B, Roche J, Nikolić K, Cuendet M, Ovádi J, Blanquart C, Bertrand P. Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design. in EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017. 2017;:19-19.
https://hdl.handle.net/21.15107/rcub_farfar_4926 .

Bouchet, Samuel, Linot, Camille, Ružić, Dušan, Agbaba, Danica, Fouchaq, Benoit, Roche, Joëlle, Nikolić, Katarina, Cuendet, Muriel, Ovádi, Judit, Blanquart, Christophe, Bertrand, Philippe, "Cross metathesis for the synthesis of HDAC inhibitors. Potential in multitarget drug design" in EpiChemBio (CM1406) and MuTaLig (CA15135) COST actions joint meeting 2017 Porto (PT), Sept 22-24 2017 (2017):19-19,
https://hdl.handle.net/21.15107/rcub_farfar_4926 .